Trial · NCT00308737
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline to Month 24 in Forced Expiratory Volume in 1 Second (FEV1) by MMRM for TI vs Usual Care | Baseline to Month 24 | Intention to Treat (ITT) | liters | MEAN |
| SECONDARY | Change From Baseline to Last Measurement in FEV1 for TI vs Usual Care | Baseline to Month 24 | Intention to Treat (ITT) with Last Observation Carried Forward (LOCF) | liters | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline to Month 24 in Forced Vital Capacity (FVC) by MMRM | Baseline to Month 24 | Intention to Treat (ITT) | liters | MEAN |
| SECONDARY | Change From Baseline to Month 24 in Total Lung Capacity (TLC) by MMRM | Baseline to Month 24 | participants in ITT population with available data | liters | MEAN |
| SECONDARY | Change From Baseline to Month 24 in Hemoglobin Corrected DLco by MMRM | Baseline to Month 24 | participants in ITT population with available data | mL/min/mmHg | MEAN |
| SECONDARY | Forced Vital Capacity (FVC) Decrease of ≥ 15% From Baseline Value at Last Measurement | Baseline to Month 24 | participants in ITT population with available data | participants | NUMBER |
| SECONDARY | Total Lung Capacity (TLC) Decrease of ≥ 15% From Baseline Value at Last Measurement | Baseline to Month 24 | participants in ITT population with available data | Participants | NUMBER |
| SECONDARY | Hemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of ≥ 15% From Baseline Value at Last Measurement | Baseline to Month 24 | participants in ITT population with available data | Participants | NUMBER |
| SECONDARY | Hemoglobin-Corrected Diffusing Capacity of the Lung for Carbon Monoxide (DLco) Decrease of >3 ml/Min/mmHg From Baseline Value at Last Measurement | Baseline to Month 24 | participants in ITT population with available data | Participants | NUMBER |
| SECONDARY | Change From Baseline in Glycated Hemoglobin A1c (HbA1c) at Last Measurement for TI vs Usual Care | Baseline to Month 24 | Intention to treat (ITT) with last observation carried forward (LOCF) | percentage | MEAN |
| SECONDARY | Change in Weight From Baseline at Month 24 | Baseline to Month 24 | Safety population at Month 24 | kilograms | MEAN |
| PRIMARY | FEV1 Decrease of ≥ 15% From Baseline Value at Last Measurement for TI vs Usual Care | Baseline to Month 24 | Intention to Treat (ITT) | Participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00308737/outcomes